{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:19:23Z","timestamp":1788985163790,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX- 77"],"award-info":[{"award-number":["ANR-10-LABX- 77"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Targeting dendritic cells (DCs) with antigens is a promising approach to modulating T follicular helper (Tfh) cells and germinal center (GC) reactions, enhancing vaccine-induced adaptive immune responses, with preclinical studies highlighting a key role of Langerhans cells (LCs) in generating HIV-1-specific antibody responses. This study evaluated the immunogenicity of a Langerin-targeting vaccine (\u03b1Lang.Env), comprising an anti-mouse Langerin mAb fused to HIV-1 Envelope 96ZM651 gp140 (Env), delivered through various skin immunization routes in mice, and explored the roles of epidermal LCs and dermal cDC1s in adaptive immune responses. Lymph nodes draining the immunization sites were analyzed using ovalbumin (OVA) as a surrogate antigen after topical (top.), subcutaneous (s.c.), intradermal (i.d.), or transcutaneous (t.c.) delivery via laser-guided microporation, with \u03b1Lang.Env administered without adjuvant in a Prime-Boost scheme. All methods primed T cells in draining lymph nodes (dLN), as shown by OVA-specific CD8<jats:sup>+<\/jats:sup> and CD4<jats:sup>+<\/jats:sup>\u2009T cell proliferation, while \u03b1Lang.Env induced GC B cells regardless of the route. However, topical delivery did not elicit Tfh cells or Env-specific GC B cells, whereas i.d. and s.c. routes produced systemic Env-specific IgG responses, with i.d. immunization yielding the highest titers and strongest Tfh responses. In the <jats:italic>Xcr1<\/jats:italic>\n            <jats:sup>DTA<\/jats:sup> mouse model, where cDC1s were depleted, the i.d. route confirmed that epidermal LCs were the primary drivers of GC\/Tfh reactions and humoral responses, while cDC1s mediated CD8<jats:sup>+<\/jats:sup>\u2009T cell effector responses. These findings highlight that i.d. administration of the HIV-1 Env antigen targeted to Langerin, without the use of an adjuvant, is an effective vaccine strategy for eliciting GC reactions in LN and generating robust antibody responses, primarily through the activation of LC.<\/jats:p>","DOI":"10.1038\/s41541-025-01214-w","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T17:01:50Z","timestamp":1753462910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting Langerhans cells via skin delivery of HIV Envelope enhances the antibody response to vaccination"],"prefix":"10.1038","volume":"10","author":[{"given":"Juliane S.","family":"Lanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Hammoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"De Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Surenaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Kembou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Zurawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Zurawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Centlivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Malissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Godot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Henri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Cardinaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"1214_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","volume":"361","author":"S Rerks-Ngarm","year":"2009","unstructured":"Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209\u20132220 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1214_CR2","doi-asserted-by":"publisher","first-page":"105320","DOI":"10.1016\/j.ebiom.2024.105320","volume":"108","author":"A Kenny","year":"2024","unstructured":"Kenny, A. et al. Immune correlates analysis of the Imbokodo (HVTN 705\/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study. eBioMedicine 108, 105320 (2024).","journal-title":"eBioMedicine"},{"key":"1214_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/infdis\/jiac260","volume":"226","author":"Z Moodie","year":"2022","unstructured":"Moodie, Z. et al. Analysis of the HIV Vaccine Trials Network 702 Phase 2b\u20133 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk. J. Infect. Dis. 226, 246\u2013257 (2022).","journal-title":"J. Infect. Dis."},{"key":"1214_CR4","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1016\/S2352-3018(24)00092-4","volume":"11","author":"Y Levy","year":"2024","unstructured":"Levy, Y. DNA and protein HIV vaccines: how should we mix it?. Lancet HIV 11, e274\u2013e275 (2024).","journal-title":"Lancet HIV"},{"key":"1214_CR5","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1016\/j.cell.2024.07.021","volume":"187","author":"R Rappuoli","year":"2024","unstructured":"Rappuoli, R., Alter, G. & Pulendran, B. Transforming vaccinology. Cell 187, 5171\u20135194 (2024).","journal-title":"Cell"},{"key":"1214_CR6","doi-asserted-by":"publisher","first-page":"949779","DOI":"10.3389\/fimmu.2022.949779","volume":"13","author":"Y Pastor","year":"2022","unstructured":"Pastor, Y. et al. Refining the DC-targeting vaccination for preventing emerging infectious diseases. Front. Immunol. 13, 949779 (2022).","journal-title":"Front. Immunol."},{"key":"1214_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/icb.2010.39","volume":"88","author":"N Romani","year":"2010","unstructured":"Romani, N., Thurnher, M., Idoyaga, J., Steinman, R. M. & Flacher, V. Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy. Immunol. Cell Biol. 88, 424\u2013430 (2010).","journal-title":"Immunol. Cell Biol."},{"key":"1214_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ebiom.2016.01.029","volume":"5","author":"W Yin","year":"2016","unstructured":"Yin, W. et al. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8 + and CD4 + T Cells. EBioMedicine 5, 46\u201358 (2016).","journal-title":"EBioMedicine"},{"key":"1214_CR9","first-page":"1","volume":"Dec 17","author":"N Salabert","year":"2015","unstructured":"Salabert, N. et al. Intradermal injection of an anti-Langerin-HIVGag fusion vaccine targets epidermal Langerhans cells in non-human primates and can be tracked in vivo. Eur. J. Immunol. Dec 17, 1\u201340 (2015).","journal-title":"Eur. J. Immunol."},{"key":"1214_CR10","doi-asserted-by":"publisher","first-page":"JVI.01596","DOI":"10.1128\/JVI.01596-16","volume":"91","author":"G Zurawski","year":"2017","unstructured":"Zurawski, G. et al. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses. J. Virol. 91, JVI.01596\u201316 (2017).","journal-title":"J. Virol."},{"key":"1214_CR11","unstructured":"Levy Y. Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06). (2024)."},{"key":"1214_CR12","doi-asserted-by":"publisher","first-page":"104062","DOI":"10.1016\/j.ebiom.2022.104062","volume":"80","author":"S Col\u00e9on","year":"2022","unstructured":"Col\u00e9on, S. et al. Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine. eBioMedicine 80, 104062 (2022).","journal-title":"eBioMedicine"},{"key":"1214_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1009025","volume":"16","author":"V Godot","year":"2020","unstructured":"Godot, V. et al. TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice. PLoS Pathog. 16, 1\u201323 (2020).","journal-title":"PLoS Pathog."},{"key":"1214_CR14","doi-asserted-by":"publisher","unstructured":"Cheng, L. et al. TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs. J. Clin. Investig.128,(2018). https:\/\/doi.org\/10.1172\/JCI99005.","DOI":"10.1172\/JCI99005"},{"key":"1214_CR15","doi-asserted-by":"publisher","unstructured":"Marlin, R. et al. Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques. Nat. Commun. (2021). https:\/\/doi.org\/10.1038\/s41467-021-25382-0.","DOI":"10.1038\/s41467-021-25382-0"},{"key":"1214_CR16","doi-asserted-by":"publisher","unstructured":"Alexandre, M. et al. Modelling the response to vaccine in nonhuman primates to define SARS-CoV-2 mechanistic correlates of protection. eLife 11, (2022). https:\/\/doi.org\/10.7554\/elife.75427.","DOI":"10.7554\/elife.75427"},{"key":"1214_CR17","doi-asserted-by":"crossref","unstructured":"Pastor, Y. et al. A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease. Cell Rep. Med. 5, 101467 (2024).","DOI":"10.1016\/j.xcrm.2024.101467"},{"key":"1214_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.immuni.2016.08.015","volume":"45","author":"M Guilliams","year":"2016","unstructured":"Guilliams, M. et al. Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species. Immunity 45, 669\u2013684 (2016).","journal-title":"Immunity"},{"key":"1214_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41577-020-00413-x","volume":"21","author":"DA Anderson","year":"2021","unstructured":"Anderson, D. A., Dutertre, C. A., Ginhoux, F. & Murphy, K. M. Genetic models of human and mouse dendritic cell development and function. Nat. Rev. Immunol. 21, 101\u2013115 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1214_CR20","doi-asserted-by":"publisher","first-page":"a028613","DOI":"10.1101\/cshperspect.a028613","volume":"10","author":"DA Anderson","year":"2018","unstructured":"Anderson, D. A., Murphy, K. M. & Brise\u00f1o, C. G. Development, Diversity, and Function of Dendritic Cells in Mouse and Human. Cold Spring Harb. Perspect. Biol. 10, a028613 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1214_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","volume":"39","author":"M Cabeza-Cabrerizo","year":"2021","unstructured":"Cabeza-Cabrerizo, M., Cardoso, A., Minutti, C. M., Pereira Da Costa, M. & Reis E Sousa, C. Dendritic Cells Revisited. Annu. Rev. Immunol. 39, 131\u2013166 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"1214_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1084\/jem.20091964","volume":"207","author":"S Henri","year":"2010","unstructured":"Henri, S. et al. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207, 189\u2013206 (2010).","journal-title":"J. Exp. Med."},{"key":"1214_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.immuni.2005.04.004","volume":"22","author":"A Kissenpfennig","year":"2005","unstructured":"Kissenpfennig, A. et al. Dynamics and function of langerhans cells in vivo: Dermal dendritic cells colonize lymph node areasdistinct from slower migrating langerhans cells. Immunity 22, 643\u2013654 (2005).","journal-title":"Immunity"},{"key":"1214_CR24","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1073\/pnas.0807126106","volume":"106","author":"K Nagao","year":"2009","unstructured":"Nagao, K. et al. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc. Natl Acad. Sci. USA 106, 3312\u20133317 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1214_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nri2455","volume":"8","author":"M Merad","year":"2008","unstructured":"Merad, M., Ginhoux, F. & Collin, M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat. Rev. Immunol. 8, 935\u2013947 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"1214_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.0105-2896.2009.00868.x","volume":"234","author":"K Crozat","year":"2010","unstructured":"Crozat, K. et al. Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets. Immunological Rev. 234, 177\u2013198 (2010).","journal-title":"Immunological Rev."},{"key":"1214_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1074-7613(00)80160-0","volume":"12","author":"J Valladeau","year":"2000","unstructured":"Valladeau, J. et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12, 71\u201381 (2000).","journal-title":"Immunity"},{"key":"1214_CR28","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1182\/blood-2011-08-371245","volume":"119","author":"J Banchereau","year":"2012","unstructured":"Banchereau, J. et al. The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Blood 119, 5742\u20135749 (2012).","journal-title":"Blood"},{"key":"1214_CR29","doi-asserted-by":"publisher","first-page":"18885","DOI":"10.1073\/pnas.1205785109","volume":"109","author":"J Banchereau","year":"2012","unstructured":"Banchereau, J. et al. Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming. Proc. Natl Acad. Sci. USA 109, 18885\u201318890 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1214_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.immuni.2008.07.013","volume":"29","author":"E Klechevsky","year":"2008","unstructured":"Klechevsky, E. et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29, 497\u2013510 (2008).","journal-title":"Immunity"},{"key":"1214_CR31","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.4049\/jimmunol.1102390","volume":"189","author":"A-L Flamar","year":"2012","unstructured":"Flamar, A.-L. et al. Noncovalent Assembly of Anti-Dendritic Cell Antibodies and Antigens for Evoking Immune Responses In Vitro and In Vivo. J. Immunol. 189, 2645\u20132655 (2012).","journal-title":"J. Immunol."},{"key":"1214_CR32","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1073\/pnas.1019547108","volume":"108","author":"J Idoyaga","year":"2011","unstructured":"Idoyaga, J. et al. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc. Natl Acad. Sci. USA 108, 2384\u20132389 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1214_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01134","volume":"10","author":"A Bouteau","year":"2019","unstructured":"Bouteau, A. et al. DC subsets regulate humoral immune responses by supporting the differentiation of distinct TFH cells. Front. Immunol. 10, 1\u201315 (2019).","journal-title":"Front. Immunol."},{"key":"1214_CR34","doi-asserted-by":"publisher","unstructured":"Kervevan, J. et al. Targeting human langerin promotes HIV-1 specific humoral immune responses. PLoS Pathogens.17, (2021). https:\/\/doi.org\/10.1371\/journal.ppat.1009749.","DOI":"10.1371\/journal.ppat.1009749"},{"key":"1214_CR35","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.4049\/jimmunol.1303339","volume":"193","author":"O Epaulard","year":"2014","unstructured":"Epaulard, O. et al. Macrophage- and Neutrophil-Derived TNF- Instructs Skin Langerhans Cells To Prime Antiviral Immune Responses. J. Immunol. 193, 2416\u20132426 (2014).","journal-title":"J. Immunol."},{"key":"1214_CR36","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/jid.2009.343","volume":"130","author":"V Flacher","year":"2010","unstructured":"Flacher, V. et al. Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis. J. investigative Dermatol. 130, 755\u2013762 (2010).","journal-title":"J. investigative Dermatol."},{"key":"1214_CR37","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.jaci.2015.04.001","volume":"136","author":"C Yao","year":"2015","unstructured":"Yao, C. et al. Skin dendritic cells induce follicular helper T cells and protective humoral immune responses. J. Allergy Clin. Immunol. 136, 1387\u20131397.e7 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1214_CR38","doi-asserted-by":"publisher","unstructured":"Wohn, C. et al. Absence of MHC class II on cDC1 dendritic cells triggers fatal autoimmunity to a cross-presented self-antigen. Sci. Immunol.5, https:\/\/doi.org\/10.1126\/sciimmunol.aba1896 (2020).","DOI":"10.1126\/sciimmunol.aba1896"},{"key":"1214_CR39","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.4049\/jimmunol.1500564","volume":"194","author":"D Terhorst","year":"2015","unstructured":"Terhorst, D. et al. Laser-Assisted Intradermal Delivery of Adjuvant-Free Vaccines Targeting XCR1 + Dendritic Cells Induces Potent Antitumoral Responses. J. Immunol. 194, 5895\u20135902 (2015).","journal-title":"J. Immunol."},{"key":"1214_CR40","first-page":"113","volume":"351","author":"N Romani","year":"2012","unstructured":"Romani, N. et al. Targeting Skin Dendritic Cells to Improve Intradermal Vaccination. Curr. Top. Microbiol Immunol. 351, 113\u2013138 (2012).","journal-title":"Curr. Top. Microbiol Immunol."},{"key":"1214_CR41","doi-asserted-by":"publisher","first-page":"6379","DOI":"10.1016\/j.vaccine.2011.04.080","volume":"29","author":"C Liard","year":"2011","unstructured":"Liard, C. et al. Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses. Vaccine 29, 6379\u20136391 (2011).","journal-title":"Vaccine"},{"key":"1214_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/eji.202149658","volume":"52","author":"TM Steiner","year":"2022","unstructured":"Steiner, T. M., Heath, W. R. & Caminschi, I. The unexpected contribution of conventional type 1 dendritic cells in driving antibody responses. Eur. J. Immunol. 52, 189\u2013196 (2022).","journal-title":"Eur. J. Immunol."},{"key":"1214_CR43","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.celrep.2016.07.076","volume":"16","author":"S Calabro","year":"2016","unstructured":"Calabro, S. et al. Differential Intrasplenic Migration of Dendritic Cell Subsets Tailors Adaptive Immunity. Cell Rep. 16, 2472\u20132485 (2016).","journal-title":"Cell Rep."},{"key":"1214_CR44","doi-asserted-by":"publisher","unstructured":"Krishnaswamy, J. K. et al. Migratory CD11b(+) conventional dendritic cells induce T follicular helper cell-dependent antibody responses. Sci. Immunol.2, https:\/\/doi.org\/10.1126\/sciimmunol.aam9169 (2017).","DOI":"10.1126\/sciimmunol.aam9169"},{"key":"1214_CR45","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1084\/jem.20170335","volume":"214","author":"MY Gerner","year":"2017","unstructured":"Gerner, M. Y., Casey, K. A., Kastenmuller, W. & Germain, R. N. Dendritic cell and antigen dispersal landscapes regulate T cell immunity. J. Exp. Med. 214, 3105\u20133122 (2017).","journal-title":"J. Exp. Med."},{"key":"1214_CR46","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.immuni.2014.12.024","volume":"42","author":"MY Gerner","year":"2015","unstructured":"Gerner, M. Y., Torabi-Parizi, P. & Germain, R. N. Strategically localized dendritic cells promote rapid T cell responses to lymph-borne particulate antigens. Immunity 42, 172\u2013185 (2015).","journal-title":"Immunity"},{"key":"1214_CR47","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.4049\/jimmunol.1102744","volume":"188","author":"C Langlet","year":"2012","unstructured":"Langlet, C. et al. CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J. Immunol. 188, 1751\u20131760 (2012).","journal-title":"J. Immunol."},{"key":"1214_CR48","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.jid.2017.04.016","volume":"137","author":"C Levin","year":"2017","unstructured":"Levin, C. et al. Critical Role for Skin-Derived Migratory DCs and Langerhans Cells in TFH and GC Responses after Intradermal Immunization. J. Investigative Dermatol. 137, 1905\u20131913 (2017).","journal-title":"J. Investigative Dermatol."},{"key":"1214_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/icb.2013.62","volume":"92","author":"A Ballesteros-Tato","year":"2014","unstructured":"Ballesteros-Tato, A. & Randall, T. D. Priming of T follicular helper cells by dendritic cells. Immunol. cell Biol. 92, 22\u201327 (2014).","journal-title":"Immunol. cell Biol."},{"key":"1214_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.02469","volume":"9","author":"M Stebegg","year":"2018","unstructured":"Stebegg, M. et al. Regulation of the germinal center response. Front. Immunol. 9, 1\u201313 (2018).","journal-title":"Front. Immunol."},{"key":"1214_CR51","doi-asserted-by":"publisher","unstructured":"Stebegg, M. et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. eLife. 9, https:\/\/doi.org\/10.7554\/eLife.52473 (2020).","DOI":"10.7554\/eLife.52473"},{"key":"1214_CR52","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.celrep.2012.05.010","volume":"2","author":"M Meyer-Hermann","year":"2012","unstructured":"Meyer-Hermann, M. et al. A theory of germinal center b cell selection, division, and exit. Cell Rep. 2, 162\u2013174 (2012).","journal-title":"Cell Rep."},{"key":"1214_CR53","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.4049\/jimmunol.180.7.4742","volume":"180","author":"D Voehringer","year":"2008","unstructured":"Voehringer, D., Liang, H.-E. & Locksley, R. M. Homeostasis and Effector Function of Lymphopenia-Induced \u201cMemory-Like\u201d T Cells in Constitutively T Cell-Depleted Mice. J. Immunol. 180, 4742\u20134753 (2008).","journal-title":"J. Immunol."},{"key":"1214_CR54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","volume":"76","author":"KA Hogquist","year":"1994","unstructured":"Hogquist, K. A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17\u201327 (1994).","journal-title":"Cell"},{"key":"1214_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1046\/j.1440-1711.1998.00709.x","volume":"76","author":"MJ Barnden","year":"1998","unstructured":"Barnden, M. J., Allison, J., Heath, W. R. & Carbone, F. R. Defective TCR expression in transgenic mice constructed using cDNA-based \u03b1- and \u03b2-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76, 34\u201340 (1998).","journal-title":"Immunol. Cell Biol."},{"key":"1214_CR56","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/1074-7613(94)90084-1","volume":"1","author":"ER Kearney","year":"1994","unstructured":"Kearney, E. R., Pape, K. A., Loh, D. Y. & Jenkins, M. K. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327\u2013339 (1994).","journal-title":"Immunity"},{"key":"1214_CR57","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nprot.2009.9","volume":"4","author":"JJ Moon","year":"2009","unstructured":"Moon, J. J. et al. Tracking epitope-specific T cells. Nat. Protoc. 4, 565\u2013581 (2009).","journal-title":"Nat. Protoc."},{"key":"1214_CR58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1600-065X.1997.tb00959.x","volume":"156","author":"KA Pape","year":"1997","unstructured":"Pape, K. A. et al. Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo. Immunological Rev. 156, 67\u201378 (1997).","journal-title":"Immunological Rev."},{"key":"1214_CR59","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/all.12005","volume":"67","author":"D Bach","year":"2012","unstructured":"Bach, D. et al. Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in P hl p 5\u2013sensitized mice. Allergy 67, 1365\u20131374 (2012).","journal-title":"Allergy"},{"key":"1214_CR60","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01214-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01214-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01214-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T01:16:01Z","timestamp":1757294161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01214-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1214"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01214-w","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"25 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare no financial or commercial conflicts of interest, except GZ and SZ are named inventors on patent filings for the use of antigens directed to LCs as vaccines (WO 2011\/032161 A3; Vaccines directed to Langerhans cells; August 25, 2011), filed by Baylor Institute for Immunology Research (Dallas, TX, USA) and licensed to Inserm Transfert (Paris, France). AH, MS, VG, YL and SC are named inventors of Langerhans cells targeting HIV-1 vaccines, filed by Inserm and University Paris-Est Cr\u00e9teil Val-de-Marne (France) licensed to Inserm Transfert (International Procedure PCT\/IB2024\/000163; March 24, 2024).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}